Document is current
Any future updates will be listed below
-
Authors
Jiménez-Santos, Maria A. https://orcid.org/0000-0002-1218-1270
Saénz-Francés, Federico https://orcid.org/0000-0002-3196-1491
Sánchez-Jean, Rubén https://orcid.org/0000-0002-9473-857X
Martinez-de-la Casa, José María https://orcid.org/0000-0001-9441-0542
García-Feijoo, Julian https://orcid.org/0000-0002-7772-5718
Jañez-Escalada, Luis https://orcid.org/0000-0002-0442-1270
- License Information
-
More Information
Article History
Received: 2 September 2020
Revised: 9 March 2021
Accepted: 19 April 2021
First Online: 7 May 2021
Declarations
:
: A cohort study was approved by the Institutional Review Board at the Hospital Clínico San Carlos, and informed consent to access and publication of their clinical records and data selected from it were obtained from all patients. The research was carried out in accordance with the principles of the Helsinki Declaration for medical research involving human subjects.
: Jimenez, M.: travel reimbursements and speaker fees by Allergan plc, Novartis. Sáenz-Francés, F.: travel reimbursements by Thea, Bausch and Lomb Inc, Allergan plc, consulting fees by Santen. Martínez-de-la-Casa, J.M.: travel reimbursements and speaker fees: Glaukos Corp, Allergan plc, Bausch and Lomb Inc, Zeiss AG, Esteve, Thea, consulting fees by Santen. García Feijóo, J.: travel reimbursements and speaker fees by Zeiss A.G., Heidelberg AG, Novartis AG, Glaukos Inc, Santen. Jáñez-Escalada, L. and Sánchez-Jean, R. declare no conflict of interest.
